News
MyChesCo on MSN11h
Aclaris Therapeutics Secures FDA Clearance for ATI-052 Clinical TrialWAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has announced that the U.S. Food and Drug Administration (FDA) has ...
Clinical Trials Arena on MSN6d
Cullinan Therapeutics receives EMA approval for rheumatoid arthritis drug trialThe trial will assess the therapy’s pharmacokinetics, pharmacodynamics and safety, as well as its impact on disease activity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback